MiMedx Group Inc
MDXG7.290USD
+0.130+1.82%
Market hours （ET）Quotes delayed by 15 min
1.08BMarket Cap
26.84P/E TTM
More Details of MiMedx Group Inc Company
MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.
Company Info
Ticker SymbolMDXG
Company nameMiMedx Group Inc
IPO dateAug 20, 2007
CEOMr. Joseph H. (Joe) Capper
Number of employees837
Security typeOrdinary Share
Fiscal year-endAug 20
Address1775 W Oak Commons Court, Ne
CityMARIETTA
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code30062
Phone17706519100
Websitehttps://mimedx.com/
Ticker SymbolMDXG
IPO dateAug 20, 2007
CEOMr. Joseph H. (Joe) Capper
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
529.53K
+60.69%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+15.53%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
190.25K
-57.15%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+18.66%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
89.04K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+98.69%
Mr. William A. (Bill) Hawkins, III
Mr. William A. (Bill) Hawkins, III
Independent Director
Independent Director
--
--
Mr. Douglas C. Rice
Mr. Douglas C. Rice
Chief Financial Officer
Chief Financial Officer
--
--
Mr. K. Todd Newton
Mr. K. Todd Newton
Independent Director
Independent Director
--
--
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
529.53K
+60.69%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+15.53%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
190.25K
-57.15%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+18.66%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
89.04K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+98.69%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
By BusinessUSD
Name
Revenue
Proportion
Advanced Wound Care
56.07M
63.57%
Surgical
32.13M
36.43%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Advanced Wound Care
56.07M
63.57%
Surgical
32.13M
36.43%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
EW Healthcare Partners
19.06%
BlackRock Institutional Trust Company, N.A.
5.80%
Trigran Investments, Inc.
5.14%
The Vanguard Group, Inc.
4.52%
Paradigm Capital Management, Inc.
3.17%
Other
62.33%
Shareholders
Shareholders
Proportion
EW Healthcare Partners
19.06%
BlackRock Institutional Trust Company, N.A.
5.80%
Trigran Investments, Inc.
5.14%
The Vanguard Group, Inc.
4.52%
Paradigm Capital Management, Inc.
3.17%
Other
62.33%
Shareholder Types
Shareholders
Proportion
Venture Capital
19.09%
Investment Advisor/Hedge Fund
18.48%
Investment Advisor
18.17%
Hedge Fund
11.43%
Research Firm
2.06%
Individual Investor
1.84%
Pension Fund
0.46%
Bank and Trust
0.39%
Sovereign Wealth Fund
0.28%
Other
27.81%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
450
106.68M
72.20%
-3.42M
2025Q1
460
106.92M
72.40%
-5.30M
2024Q4
455
107.57M
73.21%
-3.01M
2024Q3
429
103.18M
70.48%
-6.90M
2024Q2
424
100.59M
68.44%
-3.52M
2024Q1
405
106.53M
74.65%
+1.42M
2023Q4
391
100.91M
86.85%
+27.80M
2023Q3
385
72.00M
62.20%
-22.83M
2023Q2
375
65.55M
56.85%
-21.21M
2023Q1
361
82.89M
72.72%
-885.21K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
EW Healthcare Partners
28.20M
19.09%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
8.58M
5.81%
+179.59K
+2.14%
Mar 31, 2025
Trigran Investments, Inc.
7.60M
5.15%
-21.96K
-0.29%
Mar 31, 2025
The Vanguard Group, Inc.
6.69M
4.53%
+5.46K
+0.08%
Mar 31, 2025
Paradigm Capital Management, Inc.
4.68M
3.17%
-2.73K
-0.06%
Mar 31, 2025
State Street Global Advisors (US)
3.46M
2.34%
+189.21K
+5.79%
Mar 31, 2025
First Light Asset Management, LLC
3.45M
2.34%
+109.21K
+3.27%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.91M
1.97%
+133.11K
+4.79%
Mar 31, 2025
Cannell Capital, LLC
2.13M
1.44%
-1.51M
-41.39%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.01M
1.36%
+206.79K
+11.47%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Invesco NASDAQ Future Gen 200 ETF
0.43%
First Trust Small Cap Growth AlphaDEX Fund
0.26%
ALPS Barron's 400 ETF
0.18%
iShares Micro-Cap ETF
0.16%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.14%
WisdomTree US SmallCap Quality Growth Fund
0.13%
Franklin US Small Cap Multifactor Index ETF
0.12%
VictoryShares Small Cap Free Cash Flow ETF
0.1%
SPDR S&P Biotech ETF
0.1%
First Trust Small Cap Core Alphadex Fund
0.1%
View more
Invesco NASDAQ Future Gen 200 ETF
Proportion0.43%
First Trust Small Cap Growth AlphaDEX Fund
Proportion0.26%
ALPS Barron's 400 ETF
Proportion0.18%
iShares Micro-Cap ETF
Proportion0.16%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.14%
WisdomTree US SmallCap Quality Growth Fund
Proportion0.13%
Franklin US Small Cap Multifactor Index ETF
Proportion0.12%
VictoryShares Small Cap Free Cash Flow ETF
Proportion0.1%
SPDR S&P Biotech ETF
Proportion0.1%
First Trust Small Cap Core Alphadex Fund
Proportion0.1%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
